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Abstract
Murine gammaherpesvirus 68 (MHV68) is used as a model to study gammaherpesvirus pathogenesis both in tissue culture systems and in vivo. We
used a gene-trapping approach to get insight into cellular factors involved in MHV68 infection. By generating a library of gene-trapped CHO cells, we
were able to isolate several clones that exhibited various degrees of resistance to MHV68-induced cytopathic effect. Clones that showed the highest
degree of resistance were affected at the early stage of the viral cycle, with the vast majority of these clones being deficient for heparan sulfate (HS)
expression at the cell surface. Heparan sulfate expression could be restored in all the HS-deficient clones by expression of EXT1, an enzyme that is
essential for the biosynthesis of HS. Consistent with the role of HS in viral entry, HS-deficient CHO cells did not support viral internalization. Cell
surface heparan sulfate proteoglycans (HSPG) are mostly composed of HS chains attached to two families of core proteins, the transmembrane
syndecans and the GPI-anchored glypicans. Treatment of CHO cells with phosphatidylinositol-specific phospholipase C (PI-PLC) did not significantly
affect the level of HS expression, indicating that the glypicans are not a major source of HSPG in CHO cells. By contrast, treatment of CHO cells with
PMA, a drug known to accelerate syndecan shedding, resulted in a decrease in both HS expression and susceptibility to MHV68; these effects were
abolished by TIMP-3, a specific inhibitor of syndecan shedding. All together, our results confirm the essential role of HS in MHV68 infection and
identify the syndecans as a major source of HSPG used by the virus as coreceptors to infect CHO cells.
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Gammaherpesviruses are characterized by their ability to
establish latent infections in B cells. Two human gammaher-
pesviruses, Epstein–Barr virus (EBV) and Kaposi's Sarcoma
associated Herpesvirus (KSHV), are important human patho-
gens that are associated with both lymphoid and non-lymphoid
tumors (Damania, 2004). First discovered in association with
endemic Burkitt's lymphoma (Epstein et al., 1964), EBV is
associated with several other B cell malignancies (such as post-
transplant lymphoproliferative diseases, and a subset of
Hodgkin's lymphomas) and with epithelial cancers (such as
nasopharyngeal carcinoma and a subset of gastric carcinomas)
(Pagano, 1999; Young and Rickinson, 2004). KSHV is the
etiologic agent of Kaposi's sarcoma (Chang et al., 1994), a skin⁎ Corresponding author. Fax: +1 510 643 4138.
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doi:10.1016/j.virol.2007.12.004cancer prevalent in AIDS patients, as well as two AIDS-
associated lymphoproliferative disorders, primary effusion
lymphoma (Birkmann et al.) and Castelman disease (Dour-
mishev et al., 2003). With the advent of highly active anti-
retroviral therapy (HAART) regimen, the frequency of these
diseases has decreased in developed countries. However, they
remain high in other regions of the globe particularly in several
areas of Africa where the prevalence of HIV is high. EBV and
KSHV infect only humans and do not replicate efficiently in cell
lines (Ahearn et al., 1988; Bechtel et al., 2003; Blackbourn et al.,
2000; Knox et al., 1996; Renne et al., 1998). Our understanding
of gammaherpesvirus pathogenesis has been severely hindered
by the absence of animal models as well as the lack of good
tissue culture systems. Murine gammaherpesvirus 68 (MHV68)
is a natural pathogen of rodents (Blaskovic et al., 1980). Viral
genome structure and sequence analysis indicate that MHV68 is
closely related to KSHV and EBV. MHV68 genome encodes
approximately 80 open reading frames, at least 63 of which are
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EBV and KSHV in humans, MHV68 can induce lymphoproli-
ferative disease and high-grade lymphomas in long-term
infected mice (Tarakanova et al., 2005). After intranasal
inoculation, MHV68 infects epithelial cells in the lungs and
spreads to the lymphoid tissue where it infects B cells, dendritic
cells and macrophages (Flano et al., 2000; Stewart et al., 1998;
Sunil-Chandra et al., 1992). The virus establishes a life-long
infection, mostly in B cells. MHV68 replicates efficiently in
several fibroblast and epithelial cell lines, greatly facilitating the
study of host–virus interactions at the cellular level. For all these
reasons, MHV68 represents an invaluable tool to understand the
interactions between gammaherpesviruses and their hosts, both
in vitro and in vivo (Simas and Efstathiou, 1998).
Viruses hijack the whole cell machinery to suit their needs.
Forward genetics has proved useful in numerous examples to
identify cellular cofactors used by pathogens to infect host cells.
In particular, various viral receptors and coreceptors were
identified by using cDNA transfer into non-permissive cell lines
(Albritton et al., 1989; Chan et al., 2001; Feng et al., 1996;
Mendelsohn et al., 1989; Montgomery et al., 1996;Warner et al.,
1998). However, the major limitation of such approach is the
limited number of naturally non-permissive cells, and in
particular cells that are affected at a single step of the viral
cycle. Generation of loss-of-function mutants by random
mutagenesis in mammalian cell lines is still a major challenge.
Indeed, diploidy creates a major obstacle because both copies of
a gene must be altered. Yet numerous studies reported the
selection of lack-of-function mutants of the Chinese Hamster
Ovary (CHO) cell line (Carabeo and Hackstadt, 2001; Chang
et al., 1993; Esko et al., 1986; Higaki et al., 2001; Hubbard et al.,
1994; Liu and Leppla, 2003; Mento and Siminovitch, 1981;
Metherall et al., 1991; Moehring et al., 1993; Moehring and
Moehring, 1977; Nobukuni et al., 2005; Watson et al., 1991).
CHO cell mutants have been obtained at high frequencies,
mostly using chemical mutagenesis and to a lesser extent inser-
tional mutagenesis, indicating that these cells have substantial
functional hemizygosity at many loci. Gene trapping is a
powerful approach for forward genetics. Random mutagenesis
by insertion of a gene trap vector was originally developed in
embryonic stem (ES) cells in order to perform genome-wide
functional genomics in mice (Raymond and Soriano, 2006;
Stanford et al., 2001). Gene trap vectors contain a reporter gene
that is expressed only upon insertion within a gene thus allowing
selection of cells in which a copy of a gene has been disrupted.
Furthermore, the altered gene is physically marked by the vector,
thus facilitating its identification.
We decided to use a gene-trapping approach to identify
cellular factors important for MHV68 infection. The hypodi-
ploid CHO cell line is highly susceptible to MHV68 infection.
We generated a library of gene-trapped CHO cells and selected
for cells surviving MHV68 infection. We were able to isolate
about 100 clones, most of them showing only partial resistance
to MHV68-induced cytopathic effect. We focused on clones
affected in the early stages of the viral cycle and found that the
majority of them were deficient for heparan sulfate expression
at the cell surface, due to a defect in EXT1 expression. Theseclones were the most resistant to MHV68 infection thus
strengthening the essential role of HS in viral infection. Heparan
sulfate is critically required for the binding of several viruses
and bacterias. The present results reveal that forward genetic
screens involving the selection of mutant CHO cells resistant to
any of these microorganisms will likely be biased toward the
selection of HS-deficient cells. Our findings suggest that one
way to avoid this setback might be to use CHO cells stably
expressing EXT1. Finally, to further characterize MHV68-HS
interaction, we determined the nature of the heparan sulfate
proteoglycan (HSPG) in CHO cells. We provide evidence that
MHV68 uses HS carried by syndecan molecules to infect CHO
cells.
Results
Characterization of MHV68 infection in CHO cells
We first sought to verify if the hypodiploid CHO cell line
was suitable for a forward genetic screen aimed at identifying
cellular factors involved in MHV68 infection. To determine the
degree of susceptibility to MHV68, CHO cells were infected
with various multiplicity of infection (MOI) using a virus that
expresses GFP upon entry of the viral DNA into the nucleus.
The percentage of GFP-positive cells was determined by flow
cytometry 24 h post infection. As shown in Fig. 1A, CHO cells
are highly permissive to viral infection, with more than 80% of
infected cells using an MOI as low as 0.25. In all our experi-
ments, the MOI is estimated according to the viral titer mea-
sured by a standard plaque assay on NIH3T3 cells. Using the
same flow cytometry assay as above, we found that CHO are
remarkably more susceptible than BHK21 and NIH3T3 cell
lines, two cell types that are routinely used for MHV68 produc-
tion and titration respectively (data not shown). Infection led to
a complete cytopathic effect within 48 to 72 h, manifested by a
rounding of cells and detachment from the plastic surface. To
evaluate virion production in CHO cells, CHO and BHK21 cells
were infected with MHV68-GFP, washed to remove the input
virus, and a sample of the culture supernatant was taken either at
3 h or 48 h after infection. These samples were then used to
infect BHK21 cells and the extent of infection was determined
by flow cytometry after 24 h. As shown in Fig. 1B, supernatant
from BHK21-infected cells led to a high efficiency of infection
by contrast to supernatant from CHO cells. These results
indicate that, whereas CHO cells are highly permissive to
MHV68 infection and show a complete cytopathic effect, virion
production is restricted in these cells. The presence of a massive
cytopathic effect will greatly ease the isolation of resistant
clones. Moreover, the limited viral production will potentially
allow the selection of partially resistant clones by lowering the
stringency of the screen. Isolation of such clones is important.
For example, herpesviruses can use different surface receptors
(Akula et al., 2002; Kaleeba and Berger, 2006; Rappocciolo
et al., 2006; Spear, 2004). The presence of more than 1 receptor
at the cell surface would render the isolation of receptor-
deficient cells impossible in a stringent screen with continuous
viral production.
Fig. 2. Gene trapping mutagenesis and selection of MHV-68 resistant clones.
CHO cells were transduced with the ROSAbetageo ⁎ gene trap vector and
distributed in 24-well plates immediately after transduction, at approximately
50,000 cells per well. Forty-eight hours later, cells were selected in the presence
of G418 andMHV68. Viral infections were repeated 2 more times over a 3-week
period.
Fig. 1. Characterization of MHV68 infection in CHO cells. (A) CHO cells were infected with MHV68-GFP at the indicated MOI and the percentage of GFP-
expressing cells was determined by flow cytometry 24 h post-infection. (B) BHK21 or CHO cells were infected with MHV68-GFP at an MOI of 0.1. Cells were rinsed
after 2 h to remove the viral inoculum, and incubated with growth media. Samples of the growth media were then collected at 3 h or 48 h post infection. The presence of
viral particles in the growth media was determined by infecting BHK21 cells with undiluted supernatant. The percentage of GFP-positive cells was determined by
using flow cytometry 24 h later.
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MHV68-resistant clones
The ROSA gene trap vectors developed by the Soriano
laboratory (Chen and Soriano, 2003; Friedrich and Soriano,
1991) have been successfully used in numerous studies to create
mutations into the genome of mouse ES cells (Komada et al.,
2000; Komada and Soriano, 2002). The ROSAvectors include a
splice acceptor site 5′ to a promoterless reporter gene encoding
a fusion protein of βgalactosidase and neomycin phospho-
transferase (βgeo). Expression of the reporter gene requires
transcription from a cellular promoter. Because of the presence
of a splice acceptor site, insertion of the vector in an intron leads
to expression of a fusion mRNA and consequently a mutation in
the cellular gene. Moreover, this leads to expression of the βgeo
protein, conferring neomycin (G418) resistance.
We performed a small-scale experiment to determine the
trapping efficiency in CHO cells using the ROSAβgeo ⁎ vector
(Komada et al., 2000). Wild-type CHO cells are poorly permis-
sive to transduction with retroviral vectors. To increase the
efficiency of transduction, we generated a CHO cell line that
stably expresses ATRC-1, the receptor for ecotropic murine
leukemia virus (Kim et al., 1991; Wang et al., 1991). The
presence of ATRC-1 renders CHO cells highly permissive to
retroviral transduction (data not shown). To test the efficiency of
gene trapping, 50,000 CHO ATRC-1 cells were transduced with
the ROSAβgeo ⁎ vector. Forty-eight hours after transduction,
gene trap events were selected in the presence of G418. After
10 days of selection, cells were stained with Crystal violet in
order to visualize the G418-resistant clones. A total of 30 G418-
resistant clones were obtained. No clones were detected in
control cells. It is estimated that a differentiated cell expresses an
average of 10,000 genes at a given time. We reasoned that to
cover the whole expressed genome, we should obtain about
50,000 to 100,000 gene trap events. We thus decided to scale up
the experiment by a 3,000 factor, and transduced 1.5×108 cells,
that in theory should give rise to approximately 90,000 gene trapclones. Immediately after transduction, cells were distributed in
122 24-well plates (i.e. 2928 wells) to ease further isolation of
single clones (Fig. 2). Indeed, we reasoned that, given the
efficiency of gene trapping and the likelihood of selecting an
MHV68-resistant clone among them, it was unlikely to obtain
more than one MHV68-resistant clone in a well. After 48 h, we
started a concomitant selection for neomycin and MHV68 resis-
tance. Two wells were selected with G418 only to verify that the
gene-trapping efficiency was as expected. We performed a total
of 3 rounds of infections with MHV68 over a 3-week period.
Approximately 100 clones arose and were amplified. These
clones were obtained in different wells and are thus independent,
albeit possibly redundant, clones.
Fig. 4. Screening for clones showing defects in the initial steps of MHV68
infection. Wild type CHO and the gene trap clones were infected individually
with MHV68-GFP at an MOI of 0.25. The percentage of GFP-positive cells was
measured after 24 h by flow cytometry. Twelve clones are shown. ⁎ pb0.001
versus wt control.
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The clones obtained after our screening exhibited various
degrees of resistance to MHV68-induced cytopathic effect
when tested individually, the vast majority showing only a
moderate resistance (i.e. cytopathic effect not as complete as wt
cells). Two of the most resistant clones (i.e. total absence of
cytopathic effect) are shown Fig. 3. We decided to focus our
analysis on clones that were affected in the early steps of the
viral cycle. For that purpose, we took advantage of the
recombinant MHV68-GFP virus in which GFP expression is
driven by a constitutive CMV promoter. After entry of the viral
genome into the nucleus, GFP is expressed, independently of
any MHV68 gene expression. Thus, GFP expression can be
used as a marker to assess access of the viral genome to the
nucleus. Each clone was infected individually with MHV68-
GFP and the percentage of GFP-positive cells after 24 h was
determined by flow cytometry. A sample of the analysis is
shown Fig. 4. Most of the clones were not significantly different
from the control wt CHO, indicating that these clones were able
to support viral entry and access to the nucleus. By contrast, 13
clones were affected in early viral events as shown by either the
absence or reduced number of GFP-positive cells (3 are shown
Fig. 4: c1, c2 and c3). Unfortunately, our attempts to identify the
gene defects in all these clones were unsuccessful. Character-
ization of the fusion transcripts by 5′RACE revealed the usage
of a cryptic splice donor site present in the LTR region of the
gene trap vector. This cryptic site was used instead of a cellular
splice donor site and gave rise to a splicing between this region
of the LTR and the splice acceptor site upstream of the selectionFig. 3. Resistance to MHV68-induced cytopathic effect. Wild type CHO and the ge
presence (wt CHO) or absence (c1 and c3) of a cytopathic effect is shown by phasegene (data not shown). This happens when an insertion occurs
at the 5′end of genes (Medico et al., 2001), a situation that
severely hampers the cloning of the trapped transcript by 5′
RACE.
Role of the glycosaminoglycan heparan sulfate
A likely possibility was that one, or several of these clones
were deficient in cell surface expression of the glycosamino-
glycan heparan sulfate (HS). Glycosaminoglycan chains on the
cell surface proteoglycans provide initial docking sites for the
binding to cells of various viruses and other microorganisms. In
particular, numerous viruses (Liu and Thorp, 2002), includingne trap clones were infected individually with MHV68 at an MOI of 0.5. The
contrast microscopy. Two of the most resistant clones are shown.
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HS. Binding of viruses to HS provides a primary binding site
that is thought to facilitate subsequent interaction with a more
specific receptor that is necessary for viral entry. In most cases,
deficiency in HS expression dramatically affects the efficiency
of infection. To test if some of the CHO mutant clones were
deficient in cell surface HS expression, we stained the cells with
an antibody that recognizes HS and analyzed them by flow
cytometry. We found that 10 clones were deficient for HS
expression (2 of them are shown Fig. 5A). These corresponded
to the ones that were completely resistant to the cytopathic
effect. This finding confirms previous reports from Stevenson et
al. showing that HS is a critical determinant for infection by
MHV68 (de Lima et al., 2004; Gillet et al., 2007).
EXT1 is an enzyme involved in the biosynthesis of HS
(Duncan et al., 2001; McCormick et al., 2000). Its absence leads
to a total abrogation of HS synthesis (Lin et al., 2000). To test if
any of the HS-deficient clones were affected in EXT1
expression, we transfected a vector encoding EXT1-GFP intoFig. 5. Analysis of heparan-sulfate deficient clones. (A) WtCHO and the gene trap clo
clones are shown (c1 and c3). The shaded histogram corresponds to a sample stained w
an expression vector for EXT1-GFP, EXT2-GFP, or a control vector expressing GFP o
analysis is shown for one of the clones (c1), gated on the GFP-positive cells. The
internalization was monitored in wtCHO, an HS-deficient clone (c3) and an HS-positi
real-time PCR. ⁎pb0.001.these clones and tested for HS expression in the GFP-positive
cells. Remarkably, we found that HS expression was restored in
all the HS-deficient clones (Fig. 5B, only one clone is shown).
By contrast, EXT2, a closely related enzyme that acts in coop-
eration with EXT1 (McCormick et al., 2000), had no effect on
HS expression.
We performed an internalization assay to verify that viral
entry was abolished in HS-deficient cells. Wild-type CHO or
HS-deficient CHO cells (c3) were incubated with virus at 37 °C
to allow internalization, or at 4°C as a negative control. After
90 min, surface-bound virus was removed by acid stripping and
internalized viral genome was measured by quantitative PCR.
No increase in the level of viral DNAwas detected between 4 °C
and 37 °C in HS-deficient cells (c3), whereas a significant
increase was measured in wt cells (Fig. 5C). This result is
consistent with the critical role of HS in viral entry.
To gain further insight into the mechanisms of viral binding
at the cell surface, we decided to determine the nature of the
heparan sulfate proteoglycan (HSPG) used by MHV68. Cellnes were tested for HS surface expression by flow cytometry. Two HS-deficient
ith an isotype control. (B) Heparan sulfate-deficient clones were transfected with
nly. Twenty-four hours later, surface HS was determined by flow cytometry. The
shaded histogram corresponds to staining with an isotype control. (C) MHV68
ve clone (c2), at either 4 °C or 37 °C. Internalized viral genome was quantified by
Fig. 6. Nature of the HSPG present on CHO cells. CHO cells were incubated for 1 h at 37 °C in the presence of 1 U/ml of PI-PLC (A), 1 μM of PMA (or same volume
of DMSO as a control) or 1 μM PMA plus 10 μg/ml of TIMP-3 (B). After the drug treatments, HS surface expression was determined by flow cytometry. (C) Cells
were treated as in panel B (DMSO, PMA, or PMA + TIMP-3). After 1 h, cells were infected with MHV68-GFP virus. GFP expression was determined by flow
cytometry at 24 h post-infection. ⁎pb0.001 versus DMSO control; ⁎⁎ not significantly different from DMSO control.
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families of proteins, the syndecans and the glypicans (Bernfield
et al., 1999). The syndecans are a family of transmembrane
proteins that are comprised of 4 members, whereas the glypicans
are GPI-anchored proteins comprised of 6 family members. To
test if HS was bound to glypicans on CHO cells, we treated the
cells with a phosphatidylinositol-specific phospholipase C (PI-
PLC) that cleaves GPI-anchored surface molecules. Enzyme
efficacy was tested by removal of a knownGPI-anchored protein
(data not shown). As shown in Fig. 6A, PI-PLC did not
significantly alter HS expression on CHO cells, indicating that
the contribution of glypicans in surface HS was minor if any.
Syndecans are constitutively shed into the extracellular medium
(Kim et al., 1994; Spring et al., 1994), a process that can be
accelerated by PMA (Subramanian et al., 1997) . Importantly,
PMA-accelerated shedding of syndecans is specifically inhibited
by the tissue inhibitor of metalloproteinase-3 (TIMP-3)
(Fitzgerald et al., 2000). Thus, if HS is carried by syndecans,
PMA treatment should result in a reduction in HS staining, in a
TIMP-3 sensitive manner. Cells were incubated with PMA in the
presence or absence of TIMP-3, andHS expression was assessed
by flow cytometry. PMA treatment caused an 80% decrease in
HS staining (Fig. 6B; mean fluorescence intensity: 48.5 for
DMSO versus 9.64 for PMA), an effect that was abolished in the
presence of TIMP-3. PMA-treated cells showed a significant
reduction in their susceptibility to MHV68 (Fig. 6C). Full
susceptibility was restored in cells that were incubated with
PMA in the presence of TIMP-3. These results indicate that
members of the syndecan family are a major source of HSPG
used by MHV68 to infect CHO cells.
Identification of early, post-entry defects
Interestingly, c.2, c.15 and c.83 express normal level of HS
(Fig. 7A), yet they are affected in the early stages of viral
infection as shown by the reduced percentage of GFP-expressingcells following infection byMHV68-GFP (Fig. 7B). By contrast
to the HS-deficient clones, c.2, c.15 and c.83 exhibited only a
partial resistance, with c.2 and 15 showing the highest extent of
resistance, and c.83 the lowest. Increasing the MOI increased
susceptibility of c.2, c.15 and c.83 to levels comparable to that of
wt CHO, by contrast to HS-deficient cells that remained resistant
even at higher MOI (Fig. 7C). We further focused on c.2.
Importantly, sub-cloning of this clone did not give rise to cells
that were either totally susceptible or totally resistant, indicating
that the partial resistance was not due to the presence of a mixed
cell population (data not shown).We tested the efficiency of viral
internalization in this clone and found that it was comparable to
that found in wt CHO cells (Fig. 5C). These results indicate that
c.2 is deficient for a factor involved in the early step of MHV68
infection, but downstream of viral internalization.
Discussion
Here we report the characterization of CHO cell mutants that
were isolated in a screen selecting for resistance to MHV68
infection. Although a high number of clones could be selected,
the most resistant ones fell in the same category, i.e. clones
deficient for HS expression. This strengthens the point that HS
is a critical determinant of MHV68 infection. HS expression
could be restored by transfection of EXT1, indicating that the
lack of HS expression was likely due to a defect in EXT1
expression. Unexpectedly, this was true for all the HS-deficient
clones obtained in our screen. This suggests the presence of a
hot spot for either retroviral integration, or for the occurrence of
spontaneous mutations, that alter expression of EXT1 (poten-
tially at the ext1 locus or in genes controlling its expression).
Although we did not identify the retroviral insertion site in these
clones, we suspect that the high frequency of HS/EXT1 defects
might be due to the occurrence of spontaneous mutations, as
shown in L cells. Indeed, spontaneous L cell mutants defective
for HS expression were isolated in an assay screening for
Fig. 7. Analysis of heparan sulfate-positive clones, affected at early stages of
infection. (A) Three clones are shown that exhibit normal HS expression as
monitored by flow cytometry. (B and C) WtCHO cells, an HS-deficient clone
(c3), and the HS-positive clones c2, c15 and c83 were infected with MHV68-
GFP and the percentage of GFP-positive cells was examined as before.
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expression could be restored by expression of EXT1 (McCor-
mick et al., 1998). Together with the present study, these results
argue in favor of spontaneous mutations naturally occurring in
cell culture and that alter EXT1 expression. Unless there is a
selection pressure, these mutants are not observed in normal
growth conditions since the mutations do not confer a growth
advantage. We believe that, with the development of promising
new forward genetic systems, such as for example SILENCE
(Banks and Bradley, 2007), the CHO system offers a powerfultool for genetic screens in mammalian cells. However, one must
be aware that screens selecting for resistance to viruses,
bacterias and even host-ligand binding, might be severely
biased toward the selection of HS-deficient cells. Indeed, HS is
required for the binding of many microorganisms but also of
growth factors, chemokines and cytokines. Clonal selection,
rather than bulk selection, should be used in order to prevent
HS-deficient cells from taking over the culture in the detriment
of partially resistant cells. We did a semi-clonal selection
(90,000 gene trapped events distributed in approximately 3,000
wells before selection for MHV68 resistance). Among the 10
HS-deficient clones, 4 were heterogenous (i.e. a combination of
normal HS-expressing cells and HS-deficient cells, data not
shown). We believe this might be due to the appearance, during
the 3 weeks of selection, of spontaneous HS-deficient cells in a
population of partially resistant clones. This further confirms
the strong predisposition toward the selection of HS-deficient
cells. Finally, in light of our data, we believe that one way to
overcome this setback might be to use CHO cells stably
transfected with EXT1.
We confirm that heparan sulfate is a critical molecule required
for infection by MHV68, consistent with previous reports from
the Stevenson group (de Lima et al., 2004; Gillet et al., 2007) .
Viral internalization was totally abolished in HS-deficient cells.
The closely related human gammaherpesvirus, KSHV, is also
critically dependent on HS for viral entry (Akula et al., 2001b).
Heparan sulfate is used by many viruses, and microorganisms in
general, to gain access to their target cells. The common view is
that HS provides a docking site at the cell surface and by doing
so, facilitates further interaction with a more specific receptor.
However, the situation might be different in the case of MHV68.
The envelope protein gp150 is the main determinant of HS
dependence (de Lima et al., 2004). Yet, gp150 binds only weakly
to HS, by contrast to gp70 that exhibits a strong affinity for HS
(Gillet et al., 2007). Gillet et al. propose a model in which HS,
rather than promoting adhesion per se, triggers a gp150
conformational change that activates viral entry. Premature
engagement of gp150 would be prevented by gp70 binding to
soluble HS. It would be interesting to see if this is a general
control mechanism present in herpesviruses encoding several
HS-binding proteins such as KSHV (Akula et al., 2001a;
Birkmann et al., 2001; Mark et al., 2006; Wang et al., 2001).
Syndecans and glypicans are the two major families of
HSPG at the cell surface (Bernfield et al., 1999). We provide
evidence that MHV68 uses the syndecan family to infect CHO
cells. Indeed, removal of the syndecans by PMA treatment
reduced MHV68 infection, in a TIMP-3 sensitive manner. PMA
treatment did not result in a complete removal of HS from the
cell surface (20% left, Fig. 6B). Syndecans that were not shed
during the time-lapse of PMA treatment could account for the
remaining HS at the cell surface. Alternatively, a minor form of
HSPG could contribute to HS expression. The TGF-β type III
receptor, or betaglycan, has been shown to carry HS chains
under certain conditions and is accordingly referred as a part-
time HSPG (Iozzo, 2001), by contrast to syndecans and
glypicans which are called full-time HSPG. Although HS has
been thought to have a less significant role in ligand interactions
383N. Jarousse, L. Coscoy / Virology 373 (2008) 376–386with betaglycan (Esparza-Lopez et al., 2001), we cannot totally
exclude its potential contribution to viral infection of CHO
cells, in addition to the syndecans. Finally, it should be noted
that our study does not preclude the possibility that MHV68
could also use HS carried by glypicans in other cell types that
express these HSPG.
In many studies reporting virus–HS interactions, the nature
of the HSPG was not determined. However, in cases where the
nature of the proteoglycan was examined (Jones et al., 2006;
Kureishy et al., 2006; Saphire et al., 2001; Shafti-Keramat et al.,
2003), syndecans were found to be used the most often. The
structure of the core proteins might influence HS accessibility to
viruses. The syndecans have an extended structure that is
thought to position HS chains distant from the plasma mem-
brane. By contrast, glypicans have a globular conformation with
HS chains thought to lie closer to the cell surface. Alternatively,
the fact that viruses seem to use preferentially HS carried
by syndecans as coreceptors might be due to the ability of
syndecans to mediate internalization of ligands (Williams and
Fuki, 1997).
Clone 2 is affected in an early, post internalization event. The
virus is internalized normally in this clone, but access to the
nucleus is limited as shown by the reduced percentage of GFP-
expressing cells upon infection with MHV68-GFP. The
standard internalization assay that we used measures resistance
of the viral genome to acid stripping. MHV68 has been shown
to infect cells by endocytosis, with fusion events occurring in
endosomes, at least in BHK21 cells (Gill et al., 2006). Virus
trapped in endosomes would be acid-stripping resistant; thus
one possibility is that c.2 has an intact machinery allowing
internalization of MHV68 (i.e. access to an acid-stripping
resistant compartment), but lacks a surface receptor necessary
for viral fusion. Indeed, it is possible that interaction of MHV68
with HS present on syndecans triggers its endocytosis. The
actual fusion events leading to the delivery of the nucleocapsid
in the cytoplasm might involve interactions with a distinct
receptor. Such receptor for MHV68 might be missing in c.2.
Alternatively, transport of the nucleocapsid to the nucleus, or its
interaction with the nuclear pore complex might be affected in
c.2. Further characterization of this clone should give us insight




CHO-K1, NIH3T3 and BHK21 cells were from ATCC. The
packaging Bosc cell line was a generous gift from Dr. William
Sha (U.C. Berkeley, USA). CHO cells were maintained in
RPMI 1640 medium with 10% (v/v) fetal bovine serum and
penicillin–streptomycin. NIH3T3, BHK21, and Bosc cells were
grown in DMEM supplemented as described above. MHV68-
GFP was kindly provided by Dr. Herbert “Skip” Virgin
(Washington University Medical School, USA). MHV68 and
MHV68-GFP virus were produced by infection of BHK cells at
a MOI of 0.05. After a complete cytopathic effect, the culturesupernatant was titered using a standard plaque assay on
NIH3T3 cells.
Plasmids, transfections and transductions
The cDNA encoding for mouse ATRC-1, the receptor for
ecotropic murine leukemia retrovirus, was a generous gift of
Dr. Lorraine Albritton (University of Tennessee Health Science
Center, USA). A BamH1–EcoR1 restriction fragment encoding
ATRC-1was excised from pcDNA3ATRC-1 and cloned into the
retroviral vector PB-IP, a modified pBMN vector in which the
gene for neomycin phosphotransferase gene has been replaced
by the puromycin N-acetyl-transferase gene. The ROSAbeta
geo ⁎ gene trap vector was kindly provided by Dr. Philippe
Soriano (Fred Hutchinson Cancer Research Center, USA).
pEXT1-GFP and pEXT2-GFP (McCormick et al., 2000) were
kindly provided by Dr. Craig McCormick (Dalhousie Uni-
versity, Canada).
For transduction of PB-IP-ATRC-1, the packaging Bosc cell
line (one well of a six-well plate) was transfected with 1 μg of
retroviral vector mixed with 1 μg of a plasmid encoding the
VSV-G protein (pMDG). Transfection was performed using the
Fugene 6 reagent (Roche) according to the manufacturer's
instructions. The virus-containing supernatant (2 ml) was
harvested 48 h after transfection, filtered through a 0.45-μm
filter and diluted with 8 μg/ml of Polybrene (Sigma). CHO cells
(one well of a six-well plate) were transduced by spin infection
(800×g for 2 h at 20 °C) and selection for transduced cells was
started 48 h after transduction by addition of 10 μg/ml of
puromycin.
For generation of the gene trap library, seven 15-cm dishes of
Bosc cells were transfected as described above, using 105 μg of
ROSAbetageo ⁎mixed with 105 μg of pMDG. After 48 h, CHO
cells from twenty 15-cm dishes were detached using PBS 2 mM
EDTA (1.5×108 cells), spun down, and the cell pellet was
resuspended with the Bosc viral supernatant (210 ml) and
polybrene. Cells were distributed in sixteen 6-well plates and
centrifuged for 2 h as described above. Cells were then detached
using trypsin and distributed in 122 24-well plates to achieve
a density of approximately 50,000 cells per well. Forty-
eight hours later, cells were selected in the presence of 500 μg/
ml G418 and approximately 10,000 pfu of MHV68 per well.
Viral infections were repeated after 1 and 2 weeks, using the
same amount of virus (which corresponded to a much higher
MOI due to the massive cell death induced by G418 and the
initial MHV68 infection).
For transfection of EXT1-GFP, EXT2-GFP or a control
empty vector (pIRES-GFP), HS-deficient CHO cells were plated
in 6-well plates and transfected the next day using Fugene HD
(Roche). Twenty-four hours later, cells were subjected to HS
staining and flow cytometry analysis.
Flow cytometry analysis
CHO cells were detached using calcium magnesium-free
PBS 2mMEDTA. Cells were washed in PBS 1%BSA and
incubated with an anti HS antibody used at 1:100 (10E4 epitope,
384 N. Jarousse, L. Coscoy / Virology 373 (2008) 376–386F58-10E4, from Seikagaku Corporation) for 30 min at 4 °C.
The isotype control was a mouse IgMkappa (TEPC 183,
from Sigma). After two washes in PBS 1%BSA, bound antibody
was revealed by staining with a FITC- or PE -conjugated anti-
mouse IgM antibody used at 1:300 (from eBioscience). Cell
surface fluorescence was analyzed with a Becton Dickinson
FACScalibur.
To examine viral infection using MHV68 GFP, CHO cells
were plated in 12-well plates and infected 24 h later using
250 μl of virus diluted to achieve the indicated MOI. After 2 h at
37 °C, the viral inoculum was removed and replaced by 1 ml of
fresh media. Before analysis of GFP expression by flow
cytometry, cells were fixed in 4% paraformaldehyde.
Internalization assay
CHO cells were plated on 10 cm dishes (106 cells). The next
day, cells were put on ice, rinsed with cold media and incubated
with MHV68 at a MOI of 0.1, at 37 °C, or 4 °C as a negative
control. After 90 min, cells were washed 4 times with cold PBS.
Surface-bound virus was removed using two 5-min incubations
with an acid-stripping solution (135 mM NaCl, 10 mM KCl,
40 mM Citric acid, pH 3). After 2 additional washes with PBS,
cells were detached using trypsin and subjected to DNA
extraction using Proteinase K (16 h at 50 °C) and phenol–
chloroform extraction. MHV68 genome was quantified by real-
time PCR using the SYBR Green system with an Applied
Biosystems 5700 sequence detector. All samples were normal-
ized to the signal generated from the house-keeping genes
GAPDH or beta 2 microglobulin (both gave similar results). The
following primers were used: MHV68 (mK3 gene), 5′-TGA
TAC CCT TGG CTG TGC TGATGA (forward) and 5′- AGA
ACA CAATCATGG CCA GGA GGA (reverse); GAPDH, 5′-
ACG TGT CCG TTG TGG ATC TGA CAT (forward) and 5′-
AGC ATC AAA GGT GGA AGA GTG GGA (reverse); β2m,
5′-AGTCGAGCTGTCAGATCTGTCCTT (forward) and 5′-
TGG TGT GTG TAA CTC TGC AGG CAT (reverse).
Drug treatments
CHO cells were plated in 12 or 6-well plates. The next day,
cells were rinsed with serum-free media and incubated with 1U/
ml of PI-PLC (Sigma), 1μM of PMA (Sigma), or 1 μM of PMA
plus 10 μg/ml TIMP-3 (recombinant human TIMP-3 from R&D
systems) for 1 h at 37 °C. The control condition for PI-PLC
treatment was serum-free media. We verified that 1U/ml of PI-
PLC resulted in 100% removal of a known GPI-anchored
protein (CD52 in mouse splenocytes, data not shown). The
control for PMAwas DMSO (same volume as PMA) in serum-
free media.
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